Increased Expression of Inducible Cyclooxygenase-2 in Human Endothelial Cells by Antiphospholipid Antibodies

Summary The effect of IgGs from 4 patients with antiphospholipid antibodies and elevated excretion of urinary 11-dehydro-thromboxane B2 was evaluated on the production of prostacyclin by human endothelial cells in culture. After 6 h incubation, there was no change in 6-keto-prosta-glandin F1α in the supernatant. However patients’ IgGs induced a marked increase in cyclooxygenase (Cox) activity compared to IgGs from 2 normal individuals or a commercial pool of IgGs from normal donors, tested by adding exogenous arachidonic acid. Western blot analysis of the cellular Cox content using antibodies specific for the different forms of the enzymes revealed that patients’ IgGs stimulated the synthesis of the newly described inducible Cox-2 without affecting the constitutive Cox-1. This effect was partially neutralized by preincubating the IgGs with phospholipids. The induction was dependent on the amount of IgGs; it was visible at 2 h and persisted up to 24 h. Analysis of mRNA levels showed a pattern of variation in good agreement with the results obtained for protein. The protein kinase inhibitor H-7 or long-term incubation of cells with PMA strongly reduced the induction. These results suggest that antiphospholipid antibodies may not prevent the potential of the vascular cells from generating higher amounts of prostacyclin in response to acute episodes of thrombosis.

[1]  J. Maclouf,et al.  Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. , 1993, The Journal of biological chemistry.

[2]  J. Maclouf,et al.  Antiphospholipid Antibodies Enhance Thrombin-Induced Platelet Activation and Thromboxane Formation , 1993, Thrombosis and Haemostasis.

[3]  W. Dean,et al.  Are immunoglobulins with lupus anticoagulant activity specific for phospholipids? , 1993, British journal of haematology.

[4]  J. Maclouf,et al.  The lupus anticoagulant and eicosanoids. , 1993, Prostaglandins, leukotrienes, and essential fatty acids.

[5]  David A Jones,et al.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. , 1993, The Journal of biological chemistry.

[6]  S. Hart,et al.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. , 1992, The Journal of biological chemistry.

[7]  T. Hla,et al.  Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Smith Prostanoid biosynthesis and mechanisms of action. , 1992, The American journal of physiology.

[9]  M. Gerritsen,et al.  Fibroblast growth factor upregulates PGG/H synthase in rabbit microvascular endothelia cells by a glucocorticoid independent mechanism , 1992, Journal of cellular physiology.

[10]  T. Barbui,et al.  Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin , 1991, Thrombosis and Haemostasis.

[11]  J. Maclouf,et al.  Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. , 1991, Blood.

[12]  S. Machin,et al.  Guidelines for Testing and Revised Criteria for Lupus Anticoagulants , 1991, Thrombosis and Haemostasis.

[13]  H. Johnsson,et al.  Increased thromboxane formation in patients with antiphospholipid syndrome , 1990, European journal of clinical investigation.

[14]  T. Barbui,et al.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor , 1990, The Lancet.

[15]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  L. Carreras,et al.  Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant. , 1990, Haemostasis.

[17]  A. Schorer,et al.  Lupus anticoagulant induces a selective defect in thrombin‐mediated endothelial prostacyclin release and platelet aggregation , 1989, British journal of haematology.

[18]  J. Soria,et al.  Effect of Lupus Anticoagulant on Antithrombogenic Properties of Endothelial Cells - Inhibition of Thrombomodulin-Dependent Protein C Activation , 1988, Thrombosis and Haemostasis.

[19]  T. S. Walker,et al.  Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels. , 1988, Thrombosis research.

[20]  R. Derksen,et al.  Thrombosis Associated with Antiphospholipid Antibodies Cannot Be Explained by Effects on Endothelial and Platelet Prostanoid Synthesis , 1988, Thrombosis and Haemostasis.

[21]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[22]  L Roy,et al.  Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.

[23]  J. Maclouf,et al.  Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. , 1985, Analytical chemistry.

[24]  A. K. Pedersen,et al.  Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. , 1984, The New England journal of medicine.

[25]  A. Eldor,et al.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. , 1984, Archives of internal medicine.

[26]  A. Feinberg,et al.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. , 1984, Analytical biochemistry.

[27]  J. Fontcuberta,et al.  LUPUS ANTICOAGULANT, RECURRENT ABORTION, AND PROSTACYCLIN PRODUCTION BY CULTURED SMOOTH MUSCLE CELLS , 1983, The Lancet.

[28]  G. FitzGerald,et al.  Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.

[29]  J. Vermylen,et al.  “Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation , 1982, Thrombosis and Haemostasis.

[30]  J. Vermylen,et al.  “LUPUS” ANTICOAGULANT AND INHIBITION OF PROSTACYCLIN FORMATION IN PATIENTS WITH REPEATED ABORTION, INTRAUTERINE GROWTH RETARDATION AND INTRAUTERINE DEATH , 1981, British journal of obstetrics and gynaecology.

[31]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[32]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.